About Cevec Pharmaceuticals
Cevec Pharmaceuticals is a company based in Koln (Germany) founded in 2001 was acquired by Cytiva in October 2022. Cevec Pharmaceuticals has raised $28.43 million across 7 funding rounds from investors including Cytiva, NRW.Bank and Creathor Venture. The company has 39 employees as of December 31, 2020. Cevec Pharmaceuticals operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Koln, Germany
- Employees 39 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Cevec Pharmaceuticals Gmbh
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Cevec Pharmaceuticals
Unlock access to complete
Unlock access to complete
Funding Insights of Cevec Pharmaceuticals
Cevec Pharmaceuticals has successfully raised a total of $28.43M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Cevec Pharmaceuticals
Cevec Pharmaceuticals has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Cytiva, NRW.Bank and Creathor Venture.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Venture capital investments are made in life science innovations.
|
Locked | Locked | Locked | |
|
Loans, advice, seminars, and networks are provided for financial support.
|
Locked | Locked | Locked |
Investor details for Cevec Pharmaceuticals
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cevec Pharmaceuticals
Investment portfolio details for Cevec Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cevec Pharmaceuticals
Detailed financials for Cevec Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cevec Pharmaceuticals Comparisons
Peer comparison for Cevec Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cevec Pharmaceuticals
Cevec Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| Locked | Locked | Locked |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases are developed to treat patients.
|
|
| Locked | Locked | Locked |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| Locked | Locked | Locked |
Provider of cell therapies to treat cancer and hematologic conditions
|
Detailed competitors of Cevec Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cevec Pharmaceuticals
Complete news archive for Cevec Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cevec Pharmaceuticals
Cevec Pharmaceuticals was founded in 2001 and raised its 1st funding round 8 years after it was founded.
Cevec Pharmaceuticals is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.
Cevec Pharmaceuticals is a funded company, having raised a total of $28.43M across 7 funding rounds to date.
As of Dec 31, 2020, the latest employee count at Cevec Pharmaceuticals is 39.
Cevec Pharmaceuticals was founded in 2001 and is based in Cologne, Germany. Operations focus on the biotechnology sector, where glyco-optimized human suspension cell lines are developed for recombinant protein glycosylation through the CAP Go expression platform. Gene therapy vectors are produced using the scalable CAP GT system and ELEVECTA technology for AAV manufacturing. Cell line development and protein expression services are also offered to support research and production needs.
Cevec Pharmaceuticals's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Cevec Pharmaceuticals has 6 investors. Key investors include Cytiva, NRW.Bank, Creathor Venture, Peppermint Venture Partners, and Midas Group.